New analyses of microperimetry data showed positive trends with both monthly and every-other-month pegcetacoplan treatment near the GA lesion border compared to sham
These analyses provide further evidence that slowing GA lesion growth with pegcetacoplan has the potential to preserve visual function
Data were presented during an oral presentation at the American Academy of Ophthalmology Annual Meeting
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.